Alongside our named patient services, the FarmaMondo Group’s licensed medicines distribution capabilities allow optimal life cycle management in key emerging and secondary markets.
A phased combined approach in which a therapy is initially supplied on a paid access named patient basis and later gains marketing authorization optimizes patient access, drug potential and market access investments. The FarmaMondo Group offers regional partnerships for commercialization of specialty medicines in Switzerland, MENA, APAC, LATAM, Russia and CIS, and Baltic countries.
Pharmaceutical and biotech companies wishing to join our growing global partnerships portfolio may contact us at email@example.com. Further information on our global partnerships can be found in our News section.